IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction

Meraviglia-Crivelli, D. (Daniel); Villanueva-Ruiz, M.E. (María Elena); Zheleva, A. (Angelina); Villalba-Esparza, M. (María); Moreno, B. (Beatriz); Menon, A.P. (Ashwathi Puravankara); Calvo-González, A. (Alfonso); Cebollero, J. (Javier); Barainka, M. (Martin); Ruiz-de-los-Mozos, I. (Igor); Huesa-Berral, C. (Carlos); Pastor, F. (Fernando)

Keywords:

Tumor immunity
Neoantigens
Cancer immunotherapy
Immunoediting

Issue Date:

2022

Project:

872391 - cONCReTE - DevelOpmeNt of Cancer RNA TherapEutics

ISSN:

1476-4598

Note:

This article is licensed under a Creative Commons Attribution 4.0 International License

Citation:

Meraviglia-Crivelli, D.; Villanueva-Ruiz, M. (María Elena); Zheleva, A. (Angelina); et al. "IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction". Molecular Cancer. 21 (1), 2022, 211

URI:

https://hdl.handle.net/10171/65494

DOI:

10.1186/s12943-022-01679-6

Appears in Collections:

DA - CIMA - Terapias moleculares - Aptámeros - Artículos de revista

Files in This Item:

File

pdf.pdf

Description

Size

2.98 MB

Format

Adobe PDF

View/Open

Statistics and impact

Statistics

0 citas en

Google Scholar

Show full item record